adults and children over 12 years: ■ apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period ■ massage into painful area until thoroughly absorbed into skin children 12 years or younger : ask a doctor
ASPERCREME with LIDOCAINE FOOT PAIN CREAM
(For Diabetic Skin)
Drug Facts
Lidocaine HCl 4%
Topical anesthetic
temporarily relieves minor pain
For external use only
■ if you have serious foot problems, such as ulcers or infections
■ if you have numbness or reduced ability to feel pain
■ on cut, irritated or swollen skin
■on puncture wounds
■ for more than one week without consulting a doctor
■ use only as directed. Read and follow all directions and warning on this carton.
■ do not allow contact with the eyes and the mucous membranes
■ do not bandage tightly or apply local heat (such as heating pads) or a medicated patch to the area of use
■ do not use at the same time as other topical analgesics
■ condition worsens
■ redness is present
■ irritation develops
■ symptoms persist for more than 7 days or clear up and occur again within a few days
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
adults and children over 12 years:
■ apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period
■ massage into painful area until thoroughly absorbed into skin
children 12 years or younger: ask a doctor
water, alcohol denat. (10%), cetearyl alcohol, ceteth-20 phosphate, dimethicone, caprylyl methicone, dicetyl phosphate, glyceryl stearate, aloe barbadensis leaf juice, panthenol, tocopheryl acetate, magnesium ascorbyl phosphate, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, acrylates/C10-30 alkyl acrylate crosspolymer, ethylhexylglycerin, methylparaben, disodium EDTA, citric acid
333-105
Child-resistant packaging. Close cap tightly after use.
Max Strength
Aspercreme
Lidocaine
2 in 1
Pain Relief + Moisturization
foot cream
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41167-0597-0 | Aspercreme Lidocaine Foot (Diabetic) | 1 in 1 CARTON | CREAM | 1 | 4 | |
| 41167-0597-0 | Aspercreme Lidocaine Foot (Diabetic) | 113 g in 1 BOTTLE, PLASTIC | CREAM | 113 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41167-0597 | 41167-0597-0 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 3 | 2023-10-23 | full-release | 2026-05-31 23:57:06 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspercreme Lidocaine Foot (Diabetic) | LIDOCAINE HYDROCHLORIDE | Chattem, Inc. | 2c33d15e-5032-46d9-bd98-5abc7df3bbe5 | 2026-01-13 | Warnings | 41167-0597-0 41167-0597 41167059700 6e841df3-1b00-4aad-88d9-23844eb8891e 2c33d15e-5032-46d9-bd98-5abc7df3bbe5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.